CORRECTION OF IMMATERIAL ERRORS (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
|---|
| Correction of Immaterial Errors [Abstract] |
|
| Schedule of unaudited condensed consolidated interim statement of operations [Table Text Block] |
Unaudited condensed consolidated interim statement of operations for the three months ended March 31, 2025
| Line item |
|
As previously reported |
|
|
Adjustment |
|
|
As corrected |
|
| Research and development expenses |
|
- |
|
|
255,479 |
|
|
255,479 |
|
| Total operating expenses |
|
1,624,074 |
|
|
255,479 |
|
|
1,879,553 |
|
| Grant income |
|
- |
|
|
40,000 |
|
|
40,000 |
|
| Net loss |
|
2,437,628 |
|
|
215,479 |
|
|
2,653,107 |
|
| Loss per share |
|
0.12 |
|
|
0.01 |
|
|
0.13 |
|
|
| Schedule of unaudited condensed consolidated balance sheet [Table Text Block] |
Unaudited condensed consolidated balance sheet as of March 31, 2025
| Line item |
|
As previously reported |
|
|
Adjustment |
|
|
As corrected |
|
| Grant receivable |
|
- |
|
|
40,000 |
|
|
40,000 |
|
| Total current assets |
|
5,679,923 |
|
|
40,000 |
|
|
5,719,923 |
|
| Total assets |
|
12,601,612 |
|
|
40,000 |
|
|
12,641,612 |
|
| Accounts payable and accrued liabilities |
|
465,889 |
|
|
255,479 |
|
|
721,368 |
|
| Total current liabilities |
|
16,797,701 |
|
|
255,479 |
|
|
17,053,180 |
|
| Total liabilities |
|
16,934,303 |
|
|
255,479 |
|
|
17,189,782 |
|
| Accumulated deficit |
|
(19,324,443 |
) |
|
(215,479 |
) |
|
(19,539,922 |
) |
| Total stockholders' equity (deficit) |
|
(4,332,691 |
) |
|
(215,479 |
) |
|
(4,548,170 |
) |
|
| Schedule of unaudited condensed consolidated statement of cash flows [Table Text Block] |
Unaudited condensed consolidated statement of cash flows as of March 31, 2025
| Line item |
|
As previously reported |
|
|
Adjustment |
|
|
As corrected |
|
| Net loss for the year |
|
(2,437,628 |
) |
|
(215,479 |
) |
|
(2,653,107 |
) |
| Changes in non-cash working capital: Accounts payable and accrued liabilities |
|
(265,867 |
) |
|
255,479 |
|
|
(10,388 |
) |
| Grant receivable |
|
- |
|
|
(40,000 |
) |
|
(40,000 |
) |
| Net cash used in operating activities |
|
(1,669,732 |
) |
|
- |
|
|
(1,669,732 |
) |
|
| Schedule of unaudited condensed consolidated interim statements of changes in stockholders' equity (deficit) [Table Text Block] |
Unaudited condensed consolidated interim statements of changes in stockholders' equity (deficit) as of March 31, 2025
| Line item |
|
As previously reported |
|
|
Adjustment |
|
|
As corrected |
|
| Accumulated deficit |
|
(19,324,443 |
) |
|
(215,479 |
) |
|
(19,539,922 |
) |
| Total stockholders' equity (deficit) |
|
(4,332,691 |
) |
|
(215,479 |
) |
|
(4,548,170 |
) |
|